Acceleron Pharma competitors
Acceleron Pharma Competitors include Novartis, Bristol-Myers Squibb, AstraZeneca and Moderna Therapeutics.
Add company...
You can compare up to 12 companies. Please remove a company to add a new one
| Save ComparisonClear all |  Acceleron Pharma Acceleron Pharma is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics. |  Bristol-Myers Squibb Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. |  AstraZeneca AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines. |  Moderna Therapeutics Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells. | |
Founding Date | Founding Date 2003 | Founding Date 1996 | Founding Date 1887 | Founding Date 1999 | Founding Date N/A |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations New York, US HQ Vienna, AT Braine L'alleud, BE Calgary, CA Edmonton, CA Montreal, CA Toronto, CA see more | Locations Cambridge, GB HQ Sydney, AU Brussels, BE Fredericton, CA Hamilton, CA Mississauga, CA Montreal, CA see more | Locations Cambridge, US HQ Huddinge, SE Cambridge, US Cambridge, US Norwood, US Chicago, US Huntington, US | |
Employees | Employees 17324% increase | Employees 126,0004% increase | Employees 23,700 | Employees 61,100 | Employees 6801% increase |
Valuation ($) | Valuation ($) 2.3 b | Valuation ($) 175.5 b | Valuation ($) 78.6 b | Valuation ($) 107.9 b | Valuation ($) 6.3 b |
Twitter followers | Twitter followers 499 | Twitter followers 234.4 k | Twitter followers 120.8 k | Twitter followers 141.3 k | Twitter followers 2.4 k |
Financial ⚠ | |||||
Revenue (est.) | Revenue (est.) $14m (FY, 2018) | Revenue (est.) $49.1b (FY, 2017) | Revenue (est.) $22.6b (FY, 2018) | Revenue (est.) £22.5b (FY, 2017) | Revenue (est.) $205.8m (FY, 2017) |
Cost of goods | Cost of goods N/A | Cost of goods $17.2b (FY, 2017) | Cost of goods N/A | Cost of goods £4.3b (FY, 2017) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $31.9b (FY, 2017) | Gross profit N/A | Gross profit £18.1b (FY, 2017) | Gross profit N/A |
Net income | Net income ($118.9m) (FY, 2018) | Net income $7.7b (FY, 2017) | Net income $4.9b (FY, 2018) | Net income £2.9b (FY, 2017) | Net income ($255.9m) (FY, 2017) |
Operating ⚠ | |||||
Phase III Trials Products | Phase III Trials Products 2 (FY, 2016) | Phase III Trials Products 29 (Y, 2016) | Phase III Trials Products 8 (FY, 2016) | Phase III Trials Products 27 (FY, 2016) | Phase III Trials Products N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 44 (FY, 2016) | Projects in R&D Pipeline 132 (FY, 2016) | Projects in R&D Pipeline N/A |
Funding | |||||
Total funding raised | Total funding raised $ 141.8m | Total funding raised $ 6.5m | Total funding raised $ 15.5m | Total funding raised N/A | Total funding raised $ 1.7b |
For sources of this data, please see the company profileDownload Excel
View company profiles
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase
Novartis researches, develops, manufactures, and markets a range of healthcare products.
View companyBristol-Myers Squibb
HQ
New York, US
Employees
23,700
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.
View companyAstraZeneca
HQ
Cambridge, GB
Employees
61,100
AstraZeneca, a global pharmaceutical company, discovers, develops, manufactures and markets prescription medicines.
View companyModerna Therapeutics
HQ
Cambridge, US
Employees
680↑ 1% increase
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
View company